Cement Makers Project 78 Growth in FY27 Amid West Asia Headwinds But Industry Growth Could Be Moderate at 555 Global Infrastructure Funding Doubles in Five Years Japanese Banks at Forefront Applied Materials Q3 Outlook Surpasses Estimates on AI and Data Center Strength Enzo Marescas Expected Appointment as Manchester City Manager Potential Financial Implications for City Football Group Berenberg Economist Warns ECB Rate Hikes a Big Mistake Amid Stagflation Concerns Tokenization May Enable Investors to Shop for Yield Michael Saylor Suggests Posing Challenge to Traditional Finance SNEX Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction SBLK Q1 2026 Earnings Strong EPS Beat Amid Dry Bulk Headwinds Harrow Inc HROW Q1 2026 Earnings Significant EPS Miss Amid Operational Challenges STNE Q1 2026 Earnings EPS Misses Estimates Stock Slips as Growth Concerns Emerge Root Inc ROOT Q1 2026 Earnings EPS Surges 1436 Above Estimates Revenue Data Not Disclosed QTTB Q1 2026 Earnings Narrowed Loss Drives Significant Stock Surge Markel Group MKL Edges Higher as Insurer Holds Support Above 1764 Pitney Bowes PBI Edges Higher Near Resistance as Investors Weigh Growth Outlook GlucoTrack Inc GCTK Surges 8 Testing Key Resistance at 053 Voya Global Advantage Fund IGA Edges Higher at 988 Testing Support and Resistance Levels Artiva Biotherapeutics Holds Steady with Slight Gain Support at 75 in Focus ARTV US Consumer Prices Rise 38 in April Exceeding Expectations Highest Since May 2023 KW Q1 2026 Earnings Strong EPS Beat Surprises Market Insight Enterprises NSIT Surges 428 Testing Key Resistance at 10246 Beacon Financial BBT Holds Steady Near Support as Slight Decline Tests Key Levels Castor Maritime CTRM Drops 455 as Shipping Sector Headwinds Weigh on Sentiment Nutrien Ltd NTR Holds Steady Above 70 on Modest Gains Key Resistance in Sight Intellia Therapeutics NTLA Nears Key Support Amid Continued Downtrend Snowflake SNOW Surges Over 38 as Fiscal Results Propel Stock to 24196 Arteris Inc AIP Edges Higher as Bullish Momentum Builds Toward 3824 Resistance Liminatus Pharma LIMN Shares Slide 325 as Selling Pressure Mounts Near Support